World's Best Scientists 2026 revealed!
Advanced Drug Delivery Reviews
H-index 94

Advanced Drug Delivery Reviews

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 291 67 91 45

Additional Metrics

Number of Best Scientists*: 450
Documents by Best Scientists*: 539
Top 100 Ranked Scientists*: 22
SCIMAGO H-index: 386
SCIMAGO SJR: 3.721
Impact Factor: 17.6

Overview

Top Research Topics at Advanced Drug Delivery Reviews?

Advanced Drug Delivery Reviews was organized to reinforce research efforts on Drug delivery, Nanotechnology, Pharmacology, Drug and Drug carrier. The concepts on Drug delivery presented in the journal can also apply to other research fields, including Bioinformatics and Intensive care medicine. The journal explores topics in Nanotechnology which can be helpful for research in disciplines like Tissue engineering and Pharmaceutical technology.

Advanced Drug Delivery Reviews dives deep in exploring the relationship between the study of Tissue engineering and Regenerative medicine. The work tackled in Advanced Drug Delivery Reviews goes beyond the discipline of Pharmacology as it also encompasses In vivo. Most of the works presented in Advanced Drug Delivery Reviews deals with In vivo but it intersects with the subject of In vitro.

The studies on Drug carrier discussed can also contribute to research in the domains of Biochemistry, Liposome and Dosage form. The research on Biochemistry featured in Advanced Drug Delivery Reviews combines topics in other fields like Biophysics and Cell biology. The journal investigates Cell biology research which frequently intersects with Immunology.

  • Drug delivery (28.44%)
  • Nanotechnology (18.43%)
  • Pharmacology (16.99%)

What are the most cited papers published in the journal?

  • Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings (11920 citations)
  • Hydrogels for biomedical applications. (4375 citations)
  • Environment-sensitive hydrogels for drug delivery (3733 citations)

Research areas of the most cited articles at Advanced Drug Delivery Reviews:

The journal articles are organized to reinforce research efforts on Drug delivery, Nanotechnology, Drug carrier, Pharmacology and Drug. The published articles are focused mainly on Drug delivery, particularly Targeted drug delivery. The journal papers with studies in Nanotechnology featured incorporate elements of Tissue engineering, Biocompatibility and Pharmaceutical technology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Cancer

The previous edition focused in particular on these issues:

The journal facilitates discussions on Drug delivery, Computational biology, Nanotechnology, Intensive care medicine and Cancer. The work on Drug delivery tackled in Advanced Drug Delivery Reviews brings together disciplines like Risk analysis (engineering), Extracellular vesicles and Drug. It explores studies in Extracellular vesicles as part of the wider topic of Cell biology.

In addition to Computational biology research, Advanced Drug Delivery Reviews aims to explore topics under Genome editing, Messenger RNA, Genetic enhancement and Coronavirus disease 2019 (COVID-19). The research on Cancer discussed in Advanced Drug Delivery Reviews draws on the closely related field of Bioinformatics. The featured Tumor microenvironment study falls within the wider topic of Cancer research.

The most cited articles from the last journal are:

  • COVID-19 vaccines: The status and perspectives in delivery points of view. (52 citations)
  • Non-viral COVID-19 vaccine delivery systems. (43 citations)
  • Rational designs of in vivo CRISPR-Cas delivery systems. (37 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Advanced Drug Delivery Reviews (based on the number of publications) are:

  • Colin W. Pouton (23 papers) absent at the last edition,
  • Hak-Kim Chan (22 papers) published 3 papers at the last edition, 2 more than at the previous edition,
  • Nicholas A. Peppas (20 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Gert Storm (19 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Vladimir P. Torchilin (19 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Advanced Drug Delivery Reviews (based on the number of publications) are:

  • Harvard University (72 papers) published 8 papers at the last edition, 3 less than at the previous edition,
  • Massachusetts Institute of Technology (64 papers) published 7 papers at the last edition, 3 more than at the previous edition,
  • University of Utah (61 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • University of North Carolina at Chapel Hill (59 papers) published 5 papers at the last edition, 1 more than at the previous edition,
  • University of Southern California (53 papers) published 1 paper at the last edition, 3 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 1.29% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 10.49% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.52% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 22.62% of all publications and 58.36% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention

    Lisa M. Butler;Ylenia Perone;Jonas Dehairs;Leslie E. Lupien

    (2020)
    432 Citations
  • Connected healthcare: Improving patient care using digital health technologies.

    Atheer Awad;Sarah J. Trenfield;Thomas D. Pollard;Jun Jie Ong

    (2021)
    219 Citations
  • Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting.

    Josefin Soppert;Michael Lehrke;Nikolaus Marx;Joachim Jankowski

    (2020)
    216 Citations
  • Bioactive lipids, inflammation and chronic diseases.

    Alessandro Leuti;Domenico Fazio;Marina Fava;Alessandra Piccoli

    (2020)
    209 Citations
  • Controlling timing and location in vaccines.

    Darrell J. Irvine;Aereas Aung;Murillo Silva

    (2020)
    205 Citations
  • Translating 3D printed pharmaceuticals: From hype to real-world clinical applications.

    Iria Seoane-Viaño;Sarah J. Trenfield;Abdul W. Basit;Abdul W. Basit;Alvaro Goyanes;Alvaro Goyanes;Alvaro Goyanes

    (2021)
    199 Citations
  • Peptide and peptide-based inhibitors of SARS-CoV-2 entry.

    Desiree Schütz;Yasser B. Ruiz-Blanco;Jan Münch;Frank Kirchhoff

    (2020)
    175 Citations
  • Non-viral COVID-19 vaccine delivery systems.

    Kyung Soo Park;Xiaoqi Sun;Marisa E. Aikins;James J. Moon

    (2021)
    173 Citations
  • Advances in powder bed fusion 3D printing in drug delivery and healthcare.

    Atheer Awad;Fabrizio Fina;Alvaro Goyanes;Alvaro Goyanes;Alvaro Goyanes;Simon Gaisford

    (2021)
    168 Citations
  • Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies.

    Pol Escudé Martinez de Castilla;Lingjun Tong;Chenyuan Huang;Alexandros Marios Sofias

    (2021)
    152 Citations

Related Online Degrees & Career Pathways

For those interested in studying Medicine in the USA, exploring related online degrees can provide valuable career flexibility and advancement opportunities. For instance, pursuing one of the best schools for masters in nutrition can complement medical knowledge, especially in preventative care and patient wellness.

Additionally, aspiring healthcare professionals often consider becoming medical assistants. Many students find reputable medical assistant programs online Michigan that offer financial aid to ease the cost of education.

For those already working as medical assistants, bridge options like the ma to lpn bridge program online provide a pathway to becoming licensed practical nurses, unlocking more hands-on clinical roles.

Moreover, an online biology degrees can serve as a solid foundation for various medical fields, offering a broad understanding of life sciences critical to medical studies.

Best Scientists Contributing to This Journal

Recently Published Articles